Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VH3739937 in treatment-naïve HIV-1 infected adults
NCT06061081Phase 2Terminated
- Sponsor
- ViiV Healthcare
- Start
- Dec 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of GSK3739937 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Dec 2023; status: terminated.
02
Drugs
GSK3739937
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT06061081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06061081.